Background and Purpose: lymphopenia is increasingly recognized as a consequence of acute illness and may predispose to infections. We investigated whether admission lymphopenia (AL) is associated with ...

ImmunityBio, Inc.’s Anktiva shows promise for bladder cancer, but faces FDA setbacks and a rocky approval path. Peak sales for Anktiva’s indications could reach $900 million by 2028, implying a 73% ...

The ocean drives economic prosperity and environmental stability for billions of people. Yet it is under threat from overfishing, pollution and climate change. Public financing isn’t enough to respond ...

While Epogen and Neupogen addresses anemia and neutropenia, no therapy has existed for the treatment of lymphopenia until ANKTIVA® –The Cancer BioShield. Landmark overall survival benefit (P-value ...

Residential Park Lozen / IPA - Architecture and more. Image © Dian Stanchev Transforming the environment to adapt to these changes depends significantly on ...

CULVER CITY, Calif.--(BUSINESS WIRE)--ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced the U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine ...

The analysis of 11,427 Veterans Administration (VA) hospital patients with multiple myeloma (MM) reveals that lymphopenia affects 53% of patients at diagnosis. The median overall survival was 2.7 ...

A May 2024 Student Voice survey by Inside Higher Ed and Generation Lab found two in five students believe encouraging faculty to better help connect learning outcomes to issues outside the classroom ...

The NAVIGATE Project case studies were created as part of an NSF-funded project to develop a training program to help female STEM graduate students recognize—and devise strategies for dealing ...

Expert guidance abounds for enterprises to protect themselves against ransomware, phishing and other cyberattacks, but sometimes that advice is more effective when dispensed with real-world examples ...

– NKTR-255 administered post completion of concurrent chemoradiation and in combination with durvalumab demonstrated statistically significant lymphocyte recovery compared to historical controls at ...